From the labratory at Rikshospitalet with professor of clinical pharmacology Stein Bergan, specialist bioengineer Antonio Manuel Quiogue and leader of the NORCOR statin project Nils Tore Vethe.

Using clinical data and blood samples that were biobanked in the NORCOR Cross-sectional study, we will describe the prevalence of normal and reduced adherence to statin treatment with our novel direct method in more than 500 coronary outpatients. The study will also determine the relationship between the direct method and self-reported adherence measures.